Letters

How much will Herceptin really cost?

BMJ 2006; 333 doi: http://dx.doi.org/10.1136/bmj.39051.733715.3A (Published 07 December 2006) Cite this as: BMJ 2006;333:1219

Balancing local and national priorities is not new

  1. Andrew Dillon ([email protected]),
  2. Peter Littlejohns, clinical and public health director
  1. 1National Institute for Health and Clinical Excellence, London WC1V 6NA

    Herceptin for early stage breast cancer is a cost effective treatment, and it is right that the NHS should make it available. The challenge of funding new treatments and balancing local and national priorities is one the NHS has faced since its inception.1 …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe